News Overview

Aurobindo Pharma announced that CuraTeQ Biologics (CuraTeQ), a wholly owned subsidiary of the Company, has expanded the scope of its marketing and distribution agreement with Orion Corporation (Orion) to commercialize its biosimilars pipeline to include the Baltic states in Europe. Powered by Capital Market – Live News

Of the total employment estimated in the selected nine sectors, Manufacturing accounted for nearly 39%, followed by Education with 22% and Health as well as IT/BPOs sectors both around 10%.

Indices traded near the days high in mid morning trade. The Nifty hovered near the 18,050 level. Realty, pharma and IT stocks rallied while metal stocks declined. At 11:30 IST, the barometer index, the S&P BSE Sensex, rose 204.65 points or 0.34% to 60,600.43. The Nifty 50 index added 44.55 points or 0.25% to 18,047.85. In the broader market, the S&P BSE Mid-Cap index rose […]

Shreeji Translogistics has obtained in-principle approval from BSE for migration from SME platform to the main board of BSE. Powered by Capital Market – Live News

Business Wire IndiaAlgorithmic Biologics Pvt Ltd. (ABPL), a deep-tech startup building algorithms for molecular programming, today announced that it has received an undisclosed amount of seed funding from Axilor Lab. Axilor Labs is a venture curation initiative by Axilor to accelerate commercial success of transformative ideas around global challenges facing human health and wellness. They aim to support ideas at the impactful proof-of-science stage and […]

Here is the stock market performance at 11:30 AM today.

JTL Infra reported 159.63% increase in net profit to Rs 13.02 crore in Q3 FY22 from Rs 5.01 crore in Q3 FY21.

The aforesaid Ordinary Shares shall rank pari passu in all aspects with the existing Ordinary Shares of the Company.

The PLI scheme for the auto sector will incentivize high-value Advanced Automotive Technology vehicles and products.

The Reactors were manufactured at L&T’s state-of-the-art Heavy Engineering Complex located at Hazira near Surat.